Literature DB >> 25323128

Outcomes of infected cardiovascular implantable devices in dialysis patients.

Oluwaseun Opelami1, Ankit Sakhuja, Xiaobo Liu, W H Wilson Tang, Jesse D Schold, Sankar D Navaneethan.   

Abstract

BACKGROUND/AIMS: Dialysis patients are at a higher risk for cardiovascular implantable electronic device (CIED) infection-related hospitalizations. We compared the outcomes and cost for dialysis and non-dialysis patients hospitalized with CIED infections.
METHODS: We conducted a retrospective analysis of the Nationwide Inpatient Sample (NIS) discharge records from 2005 to 2010. Patients with CIED infections were identified using ICD-9 codes for device-related infections or device procedure along with bacteremia, endocarditis or systemic infection. Dialysis patients were identified using ICD-9 codes. Multivariable logistic and linear regressions were performed to examine in-hospital mortality, length of stay and cost.
RESULTS: Of the 87,798 estimated hospitalizations with CIED infections, 6,665 (7.6%) were dialysis patients. CIED-infection-related hospitalization has increased over time among dialysis patients. In-hospital mortality was higher among dialysis patients (13.6% vs. 5.9%, p < 0.001). In the multivariable model, dialysis patients had higher odds of in-hospital mortality (odds ratio 1.98; 95% CI: 1.6, 2.4) compared to the non-dialysis group. Dialysis patients had a longer median length of stay (12 days vs. 7 days, p < 0.001) and majority required extended care facility upon discharge (51.2% vs. 35.0%, p < 0.001) compared to the non-dialysis group. Dialysis status was associated with 50.3% increased cost of hospitalization (p < 0.001).
CONCLUSION: CIED-infection related hospitalization is increasing among patients undergoing dialysis and is associated with higher in-hospital mortality, longer hospital stay and higher costs of hospitalization. Future studies should examine the reasons for such a high risk and find means to improve outcomes in dialysis population.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25323128      PMCID: PMC4216629          DOI: 10.1159/000366453

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  29 in total

1.  Total hip arthroplasty in patients on long-term renal dialysis.

Authors:  D P Sakalkale; W J Hozack; R H Rothman
Journal:  J Arthroplasty       Date:  1999-08       Impact factor: 4.757

2.  Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

Authors:  Michael Allon; Thomas A Depner; Milena Radeva; James Bailey; Srinivasan Beddhu; David Butterly; Daniel W Coyne; Jennifer J Gassman; Allen M Kaufman; George A Kaysen; Julia A Lewis; Steve J Schwab
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

3.  Bacterial infections in hemodialysis patients: pathogenesis and prevention.

Authors:  Bertrand L Jaber
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

4.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

5.  Incidence and type of infections occurring in 445 chronic hemodialysis patients.

Authors:  W F Keane; F L Shapiro; L Raij
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

6.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.

Authors:  Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen Kaufman; Julia Lewis; Michael Rocco; Robert Toto; David Windus; Daniel Ornt; Andrew S Levey
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

Review 7.  Vascular and cardiac infections in end-stage renal disease.

Authors:  Farrin A Manian
Journal:  Am J Med Sci       Date:  2003-04       Impact factor: 2.378

8.  Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States.

Authors:  Kevin C Abbott; Lawrence Y Agodoa
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

9.  Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

Authors:  R N Foley; P S Parfrey; J D Harnett; G M Kent; C J Martin; D C Murray; P E Barre
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

10.  Risk of myocardial infarction and stroke after acute infection or vaccination.

Authors:  Liam Smeeth; Sara L Thomas; Andrew J Hall; Richard Hubbard; Paddy Farrington; Patrick Vallance
Journal:  N Engl J Med       Date:  2004-12-16       Impact factor: 91.245

View more
  4 in total

1.  Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.

Authors:  Georges N Nakhoul; Jesse D Schold; Susana Arrigain; Serge C Harb; Stacey Jolly; Bruce L Wilkoff; Joseph V Nally; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-25       Impact factor: 8.237

Review 2.  The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart.

Authors:  Kevin Chan; Sharon M Moe; Rajiv Saran; Peter Libby
Journal:  Eur Heart J       Date:  2021-03-31       Impact factor: 29.983

Review 3.  Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease.

Authors:  Chakradhari Inampudi; Paulino Alvarez; Rabea Asleh; Alexandros Briasoulis
Journal:  Curr Cardiol Rev       Date:  2018-03-14

4.  Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study.

Authors:  Seonjeong Jeong; Gi Byoung Nam; Jai Won Chang; Min-Ju Kim; Youngjin Han; Tae-Won Kwon; Yong-Pil Cho
Journal:  BMC Nephrol       Date:  2018-10-20       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.